Dr. Allen Richard

Dr. Allen Richard serves as a VRDD (Veterans Affairs Research and Development Director) at the Naval Medical Research Center, where he leads the acquisition and management of biomedical research and diagnostic technology contracts critical to force health protection. In this role, he ensures the procurement of innovative, field-deployable medical solutions aligned with the Department of the Navy’s strategic priorities in infectious disease surveillance, rapid diagnostics, and laboratory analytics. Dr. Richard oversees the full lifecycle of research and development contracts, from requirements definition through contract award and performance monitoring, with a focus on translational science that bridges laboratory discovery and operational readiness. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted partner in the development of specialized diagnostic platforms and biomedical instrumentation. Dr. Richard cultivates long-term, performance-driven partnerships with vendors capable of delivering high-complexity, regulatory-compliant medical technologies under austere conditions. His procurement approach emphasizes technical rigor, scientific validity, and rapid prototyping capabilities, often engaging contractors with proven expertise in clinical validation and field-testing of diagnostic systems. Dr. Richard’s acquisition portfolio is entirely non-set-aside, with 100% of contracts awarded through full and open competition. This reflects a deliberate focus on technical merit and capability over socioeconomic preferences, prioritizing mission-critical performance and innovation over programmatic set-asides. His contracting patterns indicate a preference for vendors with demonstrated expertise in high-stakes biomedical environments rather than socioeconomic categorizations. His primary NAICS focus is 621511 (Medical Laboratories), reflecting his leadership in procuring clinical testing, specimen analysis, and diagnostic assay development services. He also actively supports 541714 (Research and Development in Biotechnology), acquiring novel biosensors, molecular detection systems, and point-of-care diagnostic tools. Dr. Richard’s expertise lies at the intersection of laboratory medicine and operational military health, ensuring that procured technologies meet the demanding standards of deployed naval and marine forces.